(C) Private 2009  - Sebastian TegethoffPatenting Stem Cells - Behind the Front Stages

Today, it is still rather difficult to predict the chances of receiving the grant of a patent for stem cell technologies. Sebastian Tegethoff is a young developmental biologist and patent attorney. In this peer-reviewed and revised article he leaves aside lawyers’ advertorials in order to discuss the material meaning of biological objects which underlie legal terms, provisions, or individual litigation.

Tegethoff, S (2009): Patenting Stem Cells – Behind the Front Stages.
published online B2Bioworld, November 12: B2Bioworld.com.



If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)
5 pages, free of adverts

Article free of advertisement - 5 pages

Full Company License enquire here

Back to section

Related Editorial Articles

The Myriad Way
Peter D Meldrum, at the time CEO of the genetics company about battles on patents, cancer chips, and competitors in commercial academia

Stem Cells – Failings and Deliveries
Hugh Ilyine, longtime COO of Stem Cell Sciences looks at clinical trials, reimbursement prospects, and interest of venture capital

Improving the IP System on a global scale: A view from Japan
Sadao Nagaoka, Institute of Innovation Research, and Chief Policy Adviser to the Japanese Government

Is that worth a dollar, or a million dollars?
Ed Torres, Managing Director of Lilly Ventures on the Fund’s input to Eli Lilly’s business development

Easier Access to Patent Claims Encoded in Chinese

Teeth to the Convention on Biological Diversity
Christian Wichard, Deputy Director General of WIPO

Resolving the Innovation Paradox
Günter von Au, Vice-Chairman of the Board, Clariant AG

Thermo Fisher’s BRIMS-Strategy Under Testing

Leroy Hood: Thinking Further about Stem Cells